STOCK TITAN
  1. Home
  2. Sec-filings
  3. INFU
  4. [8-K] InfuSystem Holdings, Inc Reports Material Event

InfuSystem (NYSE: INFU) elects Beverly Huss as new board chair

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

InfuSystem Holdings, Inc. reported a board leadership change following its 2026 Annual Meeting of Stockholders held on May 11, 2026. The newly constituted Board of Directors elected Beverly Huss to serve as Chairman of the Board of Directors.

The company states that there are no arrangements or understandings with other persons related to her appointment, no family relationships between Ms. Huss and any directors or executive officers, and no material related-party transactions involving her that require disclosure under Item 404(a) of Regulation S-K.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
2026 Annual Meeting of Stockholders financial
"Following the 2026 Annual Meeting of Stockholders of InfuSystem Holdings, Inc. held on May 11, 2026"
Chairman of the Board of Directors financial
"the newly constituted Board of Directors elected Beverly Huss to serve as the Chairman of the Board of Directors"
Item 5.02 regulatory
"Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers"
Item 404(a) of Regulation S-K regulatory
"she has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K"
Inline XBRL technical
"Cover Page Interactive Data File (embedded within the Inline XBRL document)"
Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.
Understanding 8-K Material Events →
0001337013false00013370132026-05-112026-05-11

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): May 11, 2026
___________________________________
InfuSystem Holdings, Inc.
(Exact name of registrant as specified in its charter)
___________________________________
Delaware
(State or other jurisdiction of
incorporation or organization)
001-35020
(Commission File Number)
20-3341405
(I.R.S. Employer Identification Number)
3851 West Hamlin Road
Rochester Hills, Michigan 48309
  (Address of principal executive offices) (Zip Code)
(248) 291-1210
(Registrant's telephone number, including area code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
___________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
  Title of Each Class
Trading Symbol(s)
Name of Each Exchange on which Registered
Common Stock, par value $.0001 per share
INFU
NYSE American LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐





Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Following the 2026 Annual Meeting of Stockholders of InfuSystem Holdings, Inc. held on May 11, 2026, the newly constituted Board of Directors elected Beverly Huss to serve as the Chairman of the Board of Directors. There are no arrangements or understandings between Ms. Huss and any other persons, pursuant to which she was appointed as Chairman, no family relationships among any of the Company’s directors or executive officers and Ms. Huss and she has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

Item 9.01 - Financial Statements and Exhibits
(d) Exhibits

Exhibit No.
Description
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)







SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


INFUSYSTEM HOLDINGS, INC.
By:
/s/ Barry Steele
Barry Steele
Chief Financial Officer

Dated: May 14, 2026

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

3 documents

Other Documents